<html><body><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5525">international conference</a></span> on harmonisation of technical requirements for registration of pharmaceuticals for human 
use  ich harmonised tripartite <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span>   validation of analytical procedures: text and methodology q2(r1)   current step 4 version parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> dated 27 october 1994 (complementary <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> on methodology dated 6 november 1996  <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/150">incorporated</a></span> in november 2005)    this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> has been developed by the appropriate ich expert <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4543">working</a></span> group and has been subject to <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5532">consultation</a></span> by the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulatory</a></span> parties, in accordance with the ich process.  at step 4 of the process the final draft is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> for adoption to the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulatory</a></span> bodies of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/665"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/909"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4054"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4060">european</a></span></a></span></a></span> union</a></span>, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1524">japan</a></span> and usa.  q2(r1) <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> history  first codification history date new codification november 2005 parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span>: text on validation of analytical procedures q2 <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1252">approval</a></span> by the steering committee under step 2 and release for <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2859">public</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5532">consultation</a></span>.  26 october 1993 q2 q2a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1252">approval</a></span> by the steering committee under step 4 and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommendation</a></span> for adoption to the three ich <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulatory</a></span> bodies.  27 october 1994 q2 <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> on validation of analytical procedures: methodology developed to complement the parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> q2b <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1252">approval</a></span> by the steering committee under step 2 and release for <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2859">public</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5532">consultation</a></span>. 29 november 1995 in q2(r1) q2b <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1252">approval</a></span> by the steering committee under step 4 and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommendation</a></span> for adoption to the three ich 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulatory</a></span> bodies. 6 november 1996 in q2(r1) current step 4 version q2a and q2b the parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> is now renamed q2(r1) as the 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> q2b on methology has been <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/150">incorporated</a></span> to 
the parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span>.  the new title is ﬁvalidation of 
analytical procedures: text and methodologyﬂ. november 2005 q2(r1)    validation of analytical procedures:  text and methodology ich harmonised tripartite <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span>   table of contents part i: text on validation of analytical procedures..................................1 1. introduction............................................................................................................1 2. types of analytical procedures to be validated...................................................1 table.............................................................................................................................3 glossary.......................................................................................................................4  part ii: validation of analytical procedures: methodology..................6 introduction.............................................................................................................6 1. specificity.........................................................................................................6 1.1. identification.......................................................................................................7 1.2. assay and impurity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>(s)................................................................................7 2. linearity.............................................................................................................8 3. range.....................................................................................................................8 4. accuracy.............................................................................................................9 4.1. assay...................................................................................................................9 4.2. impurities (quantitation)................................................................................10 4.3. <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data..........................................................................................10 5. precision..........................................................................................................10 5.1. repeatability.....................................................................................................10 5.2. intermediate precision.....................................................................................10 5.3. reproducibility.................................................................................................10 5.4. <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data..........................................................................................10 6. detection limit............................................................................................11 6.1. based on visual evaluation.............................................................................11 6.2. based on signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span>.................................................................................11 6.3 based on the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the response and the slope.................11 6.4 <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data..........................................................................................11 i validation of analytical procedures: text and methodology    7. quantitation limit....................................................................................12 7.1. based on visual evaluation............................................................................12 7.2. based on signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> approach................................................................12 7.3. based on the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the response and the slope.................12 7.4 <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data.........................................................................................13 8. robustness.....................................................................................................13 9. system suitability <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span>..................................................................13    ii part i: text on validation of analytical procedures ich harmonised tripartite <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> having reached step 4 of the ich process at the ich steering committee meeting on 27 october 1994, this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> for adoption  to the three <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulatory</a></span> parties to ich 1. introduction this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> presents a discussion of the characteristics for consideration during the validation of the analytical procedures included as part of registration applications submitted within the ec, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1524">japan</a></span> and usa.  this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> does not necessarily seek to cover the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span> that may be required for registration in, or <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/946">export</a></span> to, other areas of the world. furthermore, this text presentation serves as a collection of terms, and their definitions, and is not intended to provide 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/448">direction</a></span> on how to accomplish validation.  these terms and definitions are meant to <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/8452">bridge</a></span> the differences that often exist between various compendia and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulators</a></span> of the ec, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1524">japan</a></span> and usa. the objective of validation of an analytical procedure is to demonstrate that it is suitable for its intended purpose.  a tabular summation of the characteristics applicable to identification, control of impurities and assay procedures is 
included.  other analytical procedures may be considered in future additions to this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span>. 2. types of analytical procedures to be validated the discussion of the validation of analytical procedures is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/448">directed</a></span> to the four most common types of analytical procedures:  - identification <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span>;  - quantitative <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> for impurities' content;  -  limit <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> for the control of impurities;  -  quantitative <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> of the active moiety in <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> of drug substance or drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> or other selected component(s) in the drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>. although there are <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5281">many</a></span> other analytical procedures, such as dissolution <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span> for drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">products</a></span></a></span> or particle size determination for drug substance, these have not been addressed in the initial text on validation of analytical procedures.  validation of these additional analytical procedures is equally <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1309">important</a></span> to those 
listed herein and may be addressed in subsequent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">documents</a></span></a></span>. a brief description of the types of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> considered in this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> is provided below.  - identification <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> are intended to ensure the identity of an analyte in a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>.  this is normally achieved by comparison of a property of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> (e.g., spectrum, chromatographic behavior, chemical reactivity, etc) to that of a reference <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span>; 1 validation of analytical procedures: text  - <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span> for impurities can be either a quantitative <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> or a limit <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> for the impurity in a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>.  either <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> is intended to accurately reflect the purity characteristics of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>. different validation characteristics are required for a quantitative <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> than for a limit <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>;  - assay procedures are intended to measure the analyte present in a given <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>.  in the context of this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span>, the assay represents a quantitative measurement of the major component(s) in the drug substance.  for the drug 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>, similar validation characteristics also apply when assaying for the active or other selected component(s).  the same validation characteristics may also apply to assays <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2944">associated</a></span> with other analytical procedures (e.g., dissolution). the objective of the analytical procedure should be clearly understood since this will <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1172"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/6897">govern</a></span></a></span> the validation characteristics which need to be evaluated.  typical validation characteristics which should be considered are listed below: accuracy precision  repeatability intermediate precision specificity detection limit quantitation limit linearity range each of these validation characteristics is defined in the attached glossary. the 
table lists those validation characteristics regarded as the most <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1309">important</a></span> for the validation of different types of analytical procedures.  this list should be considered typical for the analytical procedures cited but occasional exceptions should be dealt with on a case-by-case basis.  it should be noted that robustness is 
not listed in the table but should be considered at an appropriate stage in the development of the analytical procedure. furthermore revalidation may be necessary in the following circumstances:  - changes in the synthesis of the drug substance;  - changes in the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3122">composition</a></span> of the finished <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>;  - changes in the analytical procedure. the degree of revalidation required <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depends</a></span> on the nature of the changes. certain 
other changes may require validation as well.  2 validation of analytical procedures: text table type of analytical procedure  identification <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span>  for impurities assay - dissolution (measurement only) - content/potency characteristics  quantitat.   limit  accuracy -  + -  + precision      repeatability     interm.precision  - -   + -  + (1) -   +       + (1) specificity (2) +  + +  + detection limit -  - (3) +  - quantitation limit -  + -  - linearity -  + -  + range -  + -  + - signifies that this characteristic is not normally evaluated + signifies that this characteristic is normally evaluated (1) in cases where reproducibility (see glossary) has been performed, intermediate precision is not needed (2)  lack of specificity of one analytical procedure could be compensated by other supporting analytical procedure(s) (3) may be needed in some cases  3 validation of analytical procedures: text glossary 1. analytical procedure the analytical procedure refers to the way of performing the analysis. it should describe in detail the steps necessary to perform each analytical <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>. this may include but is not limited to: the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>, the reference <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> and the reagents 
preparations, use of the apparatus, generation of the calibration curve, use of the 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1076">formulae</a></span> for the calculation, etc. 2. specificity specificity is the ability to <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/184">assess</a></span> unequivocally the analyte in the presence of 
components which may be expected to be present. typically these might include impurities, degradants, matrix, etc. lack of specificity of an individual analytical procedure may be compensated by other supporting analytical procedure(s). this definition has the following implications: identification: to ensure the identity of an analyte.  purity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span>:  to ensure that all the analytical procedures performed allow an                    accurate <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/883">statement</a></span> of the content of impurities of an analyte, i.e. 
related substances <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>, heavy <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1882">metals</a></span>, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3460">residual</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4211">solvents</a></span> content, etc.  assay (content or potency):   to provide an exact result which allows an accurate <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/883">statement</a></span>  on the content or potency of the analyte in a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>. 3. accuracy the accuracy of an analytical procedure expresses the closeness of agreement between the value which is accepted either as a conventional true value or an accepted 
reference value and the value found. this is sometimes termed trueness. 4. precision  the precision of an analytical procedure expresses the closeness of agreement (degree of scatter) between a series of measurements obtained from multiple <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sampling</a></span> of the 
same homogeneous <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> under the prescribed conditions. precision may be 
considered at three levels:  repeatability, intermediate precision and reproducibility. precision  should be investigated using homogeneous, authentic <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span>. however, if it is not possible to obtain a homogeneous <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> it may be investigated using 
artificially prepared <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> or a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> solution. the precision of an analytical procedure is usually expressed as the variance, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation or coefficient of variation of a series of measurements. 4 validation of analytical procedures: text 4.1. repeatability repeatability expresses the precision under the same operating conditions over a short interval of time. repeatability is also termed intra-assay precision . 4.2. intermediate precision intermediate precision expresses within-laboratories variations: different days, different analysts, different equipment, etc. 4.3. reproducibility reproducibility expresses the precision between laboratories (collaborative studies, usually applied to standardization of methodology). 5. detection limit  the  detection limit of an individual analytical procedure is the lowest amount of analyte in a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> which can be detected but not necessarily quantitated as an exact value. 6. quantitation limit the quantitation limit of an individual analytical procedure is the lowest amount of analyte in a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> which can be quantitatively determined with suitable precision and accuracy. the quantitation limit is a parameter of quantitative assays for low 
levels of compounds in <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> matrices, and is used particularly for the determination of impurities and/or degradation <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">products</a></span></a></span>. 7. linearity the linearity of an analytical procedure is its ability (within a given range)  to obtain <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> results which are <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/448">directly</a></span>  proportional to the concentration (amount) of analyte in the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>. 8. range the range of an analytical procedure is the interval between the upper and lower concentration (amounts) of analyte in the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of precision, accuracy and linearity. 9. robustness the robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage. 5 part ii: validation of analytical procedures: methodology ich harmonised tripartite <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> having reached step 4 of the ich process at the ich steering committee meeting on 6 november 1996, and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/150">incorporated</a></span> into the core <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> in november 2005, this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> for adoption to the three <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3099">regulatory</a></span> parties to ich  introduction this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> is complementary to the parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> which presents a discussion of the characteristics that should be considered during the validation of analytical procedures. its purpose is to provide some <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guidance</a></span> and recommendations on how to consider the various validation characteristics for each analytical procedure. in some cases (for example, demonstration of specificity), the overall capabilities of a number 
of analytical procedures in combination may be investigated in order to ensure the quality of the drug substance or drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>. in addition, the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> provides an indication of the data which should be presented in a registration application . all relevant <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/6030">data collected</a></span> during validation and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1076">formulae</a></span> used for calculating validation characteristics should be submitted and discussed as appropriate. approaches other than those set forth in this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5311">guideline</a></span> may be applicable and 
acceptable. it is the responsibility of the applicant to choose the validation procedure and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/6884">protocol</a></span> most suitable for their <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>. however it is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1309">important</a></span> to remember that the main objective of validation of an analytical procedure is to demonstrate that the procedure is suitable for its intended purpose. due to their complex nature, analytical procedures for <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4921">biological</a></span> and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3797">biotechnological</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">products</a></span></a></span> in some cases may be approached differently than in this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span>. well-characterized reference materials, with <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">documented</a></span></a></span> purity, should be used 
throughout the validation study. the degree of purity necessary <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depends</a></span> on the 
intended use. in accordance with the parent <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span>, and for the sake of clarity, this <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/486"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/494">document</a></span></a></span> 
considers the various validation characteristics in distinct <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3803">sections</a></span>. the arrangement of these <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3803">sections</a></span> reflects the process by which an analytical procedure may be developed and evaluated. in practice, it is usually possible to design the experimental <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4543">work</a></span> such that the appropriate validation characteristics can be considered simultaneously to provide a 
sound, overall knowledge of the capabilities of the analytical procedure, for instance: specificity, linearity, range, accuracy and precision. 1. specificity an investigation of specificity should be conducted during the validation of identification <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span>, the determination of impurities and the assay. the procedures 
used to demonstrate specificity will <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depend</a></span> on the intended objective of the analytical procedure.  it is not always possible to demonstrate that an analytical procedure is specific for a particular analyte (complete discrimination). in this case a combination of two or 6 validation of analytical procedures: methodology more analytical procedures is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> to achieve the necessary level of discrimination. 1.1. identification  suitable identification <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> should be able to discriminate between compounds of closely related structures which are likely to be present. the discrimination of a procedure may be confirmed by obtaining positive results (perhaps by comparison with a known reference material) from <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/158">containing</a></span> the analyte, coupled with negative results from <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> which do not <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/158">contain</a></span> the analyte. in addition, the identification <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> may be applied to materials structurally similar to or closely related to the analyte to confirm that a positive response is not obtained. the choice of 
such potentially <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1436">interfering</a></span> materials should be based on sound scientific <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1537">judgement</a></span> with a consideration of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1436">interferences</a></span> that could occur.  1.2. assay and impurity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>(s)  for chromatographic procedures, representative chromatograms should be used to demonstrate specificity and individual components should be appropriately <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/893">labelled</a></span>. similar considerations should be given to other separation techniques.  critical separations in chromatography should be investigated at an appropriate level. for critical separations, specificity can be demonstrated by the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3470">resolution</a></span> of the two components which elute closest to each other. in cases where a non-specific assay is used, other supporting analytical procedures should be used to demonstrate overall specificity. for example, where a titration is adopted to assay the drug substance for release, the combination of the assay and a 
suitable <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> for impurities can be used. the approach is similar for both assay and impurity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span>: 1.2.1 impurities are available for the assay , this should involve demonstration of the discrimination of the analyte 
in the presence of impurities and/or excipients; practically, this can be done by spiking pure substances (drug substance or drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>) with appropriate levels of impurities and/or excipients and demonstrating that the assay result is unaffected by 
the presence of these materials (by comparison with the assay result obtained on 
unspiked <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span>). for the impurity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>, the discrimination may be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span> by spiking drug substance or drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> with appropriate levels of impurities and demonstrating the separation of these impurities individually and/or from other components in the 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> matrix. 1.2.2 impurities are not available if impurity or degradation <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standards</a></span> are unavailable, specificity may be demonstrated by comparing the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> results of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/158">containing</a></span> impurities or degradation <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">products</a></span></a></span> to a second well-characterized procedure e.g.: pharmacopoeial method or other validated analytical procedure (independent procedure). as appropriate, this should include <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> stored under relevant stress conditions: <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/626">light</a></span>, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5503">heat</a></span>, humidity, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5035">acid</a></span>/base hydrolysis and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2213">oxidation</a></span>.  - for the assay, the two results should be compared; 7 validation of analytical procedures: methodology - for the impurity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span>, the impurity profiles should be compared. peak purity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> may be useful to show that the analyte chromatographic peak is not attributable to more than one component (e.g., diode array, mass spectrometry). 2. linearity a linear <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2239">relationship</a></span> should be evaluated across the range (see <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3803">section</a></span> 3) of the analytical procedure. it may be demonstrated <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/448">directly</a></span> on the drug substance (by dilution of a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4280">stock</a></span> solution) and/or separate weighings of synthetic mixtures 
of the drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> components, using the proposed procedure. the latter aspect can be studied during investigation of the range. linearity should be evaluated by visual inspection of a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2237">plot</a></span> of signals as a function of analyte concentration or content. if there is a linear <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2239">relationship</a></span>, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> results should 
be evaluated by appropriate <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1895"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4256">statistical</a></span> methods</a></span>, for example, by calculation of a 
regression line by the method of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/4598">least</a></span> squares. in some cases, to obtain linearity 
between assays and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> concentrations, the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> data may need to be subjected to 
a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1835">mathematical</a></span> transformation prior to the regression analysis. data from the regression line itself may be helpful to provide <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1835">mathematical</a></span> estimates of the degree of linearity.  the correlation coefficient, y-intercept, slope of the regression line and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3460">residual</a></span> sum of 
squares should be submitted. a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2237">plot</a></span> of the data should be included. in addition, an 
analysis of the deviation of the actual data points from the regression line may also be 
helpful for evaluating linearity. some analytical procedures, such as immunoassays, do not demonstrate linearity after any transformation. in this case, the analytical response should be described by an appropriate function of the concentration (amount) of an analyte in a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span>.  for the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">establishment</a></span> of linearity, a minimum of 5 concentrations is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span>. 
other approaches should be justified. 3. range  the specified range is normally derived from linearity studies and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depends</a></span> on the intended application of the procedure. it is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span> by confirming that the analytical procedure provides an acceptable degree of linearity, accuracy and precision when applied to <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/158">containing</a></span> amounts of analyte within or at the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5634">extremes</a></span> of the specified range of the analytical procedure.  the following minimum specified ranges should be considered: - for the assay of a drug substance or a finished (drug) <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>: normally from 80 to 120 percent of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> concentration;  - for content uniformity, covering a minimum of 70 to 130 percent of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> concentration, unless a wider more appropriate range, based on the nature of the 
dosage <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1076">form</a></span> (e.g., metered dose inhalers), is justified; - for dissolution <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span>: +/-20 % over the specified range;  e.g., if the specifications for a controlled released <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> cover a <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3031"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3096">region</a></span></a></span> from 20%, after 1 hour, up to 90%, after 24 hours, the validated range would be 0-110% of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/893">label</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5559">claim</a></span>.  8 validation of analytical procedures: methodology - for the determination of an impurity: from the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2891">reporting</a></span> level of an impurity1 to 120% of the specification;  - for impurities known to be unusually potent or to produce toxic or unexpected <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2367">pharmacological</a></span> effects, the detection/quantitation limit should be commensurate with the level at which the impurities must be controlled; note: for validation of impurity <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> procedures carried out during development, it may be necessary to consider the range around a suggested (probable) limit. - if assay and purity are performed together as one <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> and only a 100% <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> is used, linearity should cover the range from the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2891">reporting</a></span> level of the impurities1 to 120% of the assay specification. 4. accuracy accuracy should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span> across the specified range of the analytical procedure.  4.1. assay 4.1.1 drug substance several methods of determining accuracy are available: a) application of an analytical procedure to an analyte of known purity (e.g. reference material); b) comparison of the results of the proposed analytical procedure with those of a second well-characterized procedure, the accuracy of which is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/883">stated</a></span> and/or defined (independent procedure, see 1.2.); c) accuracy may be inferred once precision, linearity and specificity have been <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span>. 4.1.2 drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> several methods for determining accuracy are available: a) application of the analytical procedure to synthetic mixtures of the drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> components to which known quantities of the drug substance to be analysed have been added; b) in cases where it is impossible to obtain <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> of all drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> components , it may be acceptable either to add known quantities of the analyte to the drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span> or to compare the results obtained from a second, well characterized 
procedure, the accuracy of which is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/883">stated</a></span> and/or defined (independent procedure, see 1.2.); c) accuracy may be inferred once precision, linearity and specificity have been <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span>.                                                  1 see chapters ﬁreporting impurity content of batchesﬂ of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/242">corresponding</a></span> ich-guidelines: ﬁimpurities in new drug substancesﬂ and ﬁimpurities in new drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">productsﬂ</a></span></a></span>  9 validation of analytical procedures: methodology 4.2. impurities (quantitation) accuracy should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/184">assessed</a></span> on <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> (drug substance/drug <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">product</a></span></a></span>) spiked with known amounts of impurities. in cases where it is impossible to obtain <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> of certain impurities and/or degradation <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2707"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2724">products</a></span></a></span>, it is considered acceptable to compare results obtained by an independent procedure (see 1.2.). the response factor of the drug substance can be used. it should be clear how the individual or total impurities are to be determined e.g., weight/weight or area percent, in all cases with respect to the major analyte. 4.3. <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data accuracy should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/184">assessed</a></span> using a minimum of 9 determinations over a minimum of 
3 concentration levels covering the specified range (e.g., 3 concentrations/3 replicates each of the total analytical procedure). accuracy should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2891">reported</a></span> as percent recovery by the assay of known added amount of analyte in the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">sample</a></span> or as the difference between the mean and the accepted true 
value together with the confidence intervals. 5. precision validation of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> for assay and for quantitative determination of impurities includes an investigation of precision. 5.1. repeatability repeatability should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/184">assessed</a></span> using: a) a minimum of 9 determinations covering the specified range for the procedure (e.g., 3 concentrations/3 replicates each); or b) a minimum of 6 determinations at 100% of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> concentration. 5.2. intermediate precision the extent to which intermediate precision should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depends</a></span> on the 
circumstances under which the procedure is intended to be used. the applicant should <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">establish</a></span> the effects of random events on the precision of the analytical procedure. typical variations to be studied include days, analysts, equipment, etc. it is not considered necessary to study these effects individually. the use of an experimental design (matrix) is encouraged. 5.3. reproducibility reproducibility is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/184">assessed</a></span> by means of an inter-laboratory trial. reproducibility should be considered in case of the standardization of an analytical procedure, for instance, for inclusion of procedures in pharmacopoeias. these data are not part of the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/13"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1786">marketing</a></span></a></span> authorization dossier.  5.4. <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation, relative <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation (coefficient of variation) and confidence interval should be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2891">reported</a></span> for each type of precision investigated. 10 validation of analytical procedures: methodology 6. detection limit several approaches for determining the detection limit are possible, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depending</a></span> on whether the procedure is a non-instrumental or instrumental. approaches other than those listed below may be acceptable. 6.1. based on visual evaluation visual evaluation may be used for non-instrumental methods but may also be used with instrumental methods. the detection limit is determined by the analysis of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> with known concentrations of analyte and by <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">establishing</a></span> the minimum level at which the analyte can be reliably detected. 6.2. based on signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span>  this approach can only be applied to analytical procedures which exhibit baseline <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span>. determination of the signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2902">ratio</a></span> is performed by comparing measured signals from <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> with known low concentrations of analyte with those of blank 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">establishing</a></span> the minimum concentration at which the analyte can be 
reliably detected. a signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2902">ratio</a></span> between 3 or 2:1 is generally considered acceptable for estimating the detection limit. 6.3 based on the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the response and the slope the detection limit (dl) may be expressed as: dl = 3.3   s where  = the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the response   s = the slope of the calibration curve the slope s may be estimated from the calibration curve of the analyte. the estimate 
of  may be carried out in a variety of ways, for example:  6.3.1 based on the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the blank measurement of the magnitude of analytical background response is performed by analyzing an appropriate number of blank <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> and calculating the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> 
deviation of these responses.  6.3.2 based on the calibration curve a specific calibration curve should be studied using <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/158">containing</a></span> an analyte in the range of dl. the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3460">residual</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of a regression line or the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of y-intercepts of regression lines may be used as the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation.  6.4 <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data the detection limit and the method used for determining the detection limit should be 
presented. if dl is determined based on visual evaluation or based on signal to <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2902">ratio</a></span>, the presentation of the relevant chromatograms is considered acceptable for justification. 11 validation of analytical procedures: methodology in cases where an estimated value for the detection limit is obtained by calculation or extrapolation, this estimate may subsequently be validated by the independent analysis of a suitable number of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> known to be near or prepared at the detection limit.  7. quantitation limit several approaches for determining the quantitation limit are possible, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depending</a></span> on whether the procedure is a non-instrumental or instrumental. approaches other than those listed below may be acceptable. 7.1. based on visual evaluation visual evaluation may be used for non-instrumental methods but may also be used with instrumental methods. the quantitation limit is generally determined by the analysis of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> with known concentrations of analyte and by <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">establishing</a></span> the minimum level at which the analyte can be quantified with acceptable accuracy and precision.  7.2. based on signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> approach this approach can only be applied to analytical procedures that exhibit baseline <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span>. determination of the signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2902">ratio</a></span> is performed by comparing measured signals from <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> with known low concentrations of analyte with those of blank 
<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> and by <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">establishing</a></span> the minimum concentration at which the analyte can be reliably quantified. a typical signal-to-<span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5048">noise</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2902">ratio</a></span> is 10:1.  7.3. based on the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the response and the slope the quantitation limit (ql) may be expressed as: ql = 10   s where  = the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the response   s = the slope of the calibration curve the slope s may be estimated from the calibration curve of the analyte. the estimate 
of  may be carried out in a variety of ways for example:  7.3.1 based on <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of the blank measurement of the magnitude of analytical background response is performed by analyzing an appropriate number of blank <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> and calculating the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> 
deviation of these responses.  7.3.2 based on the calibration curve a specific calibration curve should be studied using <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span>, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/158">containing</a></span> an analyte in the range of ql. the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3460">residual</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of a regression line or the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation of y-intercepts of regression lines may be used as the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2077">standard</a></span> deviation.  12 validation of analytical procedures: methodology 7.4 <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2926">recommended</a></span> data the quantitation limit and the method used for determining the quantitation limit should be presented. the limit should be subsequently validated by the analysis of a suitable number of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> known to be near or prepared at the quantitation limit.  8. robustness the evaluation of robustness should be considered during the development phase and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depends</a></span> on the type of procedure under study. it should show the reliability of an 
analysis with respect to deliberate variations in method parameters. if measurements are susceptible to variations in analytical conditions, the analytical conditions should be suitably controlled or a precautionary <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/883">statement</a></span> should be included in the procedure. one consequence of the evaluation of robustness should be that a series of system suitability parameters (e.g., <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3470">resolution</a></span> <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span>) is <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span> to ensure that the validity of the analytical procedure is maintained whenever used. examples of typical variations are: - stability of analytical solutions; - extraction time. in the case of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1672">liquid</a></span> chromatography, examples of typical variations are: - influence of variations of ph in a mobile phase; - influence of variations in mobile phase <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/3122">composition</a></span>; - different columns (different lots and/or <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1078"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2292">suppliers</a></span></a></span>); - temperature; - flow rate. in the case of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1139">gas</a></span>-chromatography, examples of typical variations are: - different columns (different lots and/or <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1078"><span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/2292">suppliers</a></span></a></span>); - temperature; - flow rate. 9. system suitability <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span> system suitability <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">testing</a></span> is an integral part of <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5281">many</a></span> analytical procedures. the <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">tests</a></span> are based on the concept that the equipment, <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/709">electronics</a></span>, analytical operations and <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/623">samples</a></span> to be analyzed <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/148">constitute</a></span> an integral system that can be evaluated as such. system suitability <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/867">test</a></span> parameters to be <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/871">established</a></span> for a particular procedure <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/5390">depend</a></span> on the type of procedure being validated. see pharmacopoeias for additional <span style="background-color: #FFFF00"><a href="http://eurovoc.europa.eu/1422">information</a></span>.  13 </body><html>